About us

We develop and manufacture novel biologics and biosimilars for biotechnology companies around the planet, including for our own portfolio which we look to partner and out-licence.

We create quality biologics with passion from our three sites in Poland and the Netherlands, these are some of the most modern and largest facilities in Europe.

Our history

Creating quality biologics with passion

We are passionate about providing safe and effective medicines to patients.

We work with dedication and find innovative solutions.

We are self-motivated to reach the end result - “wait and see” is not in our vocabulary.

Delivering on our commitments

We are committed to positive outcomes and delivering projects on time, to specification.

We are experts in managing projects and communicate clearly and concisely.

We anticipate potential issues before they arise, always ensuring high quality outcomes.

Being respectful and transparent

We are open and honest without exception.

We value everyone equally and always treat others with respect.

We like to collaborate and can rely on each other.

What we do

Our mission is to create quality biologics with a passion to improve the lives of patients. We do this through two streams of business:

Novel biologics & biosimilar portfolio

We have our own pipeline of novel biologics & biosimilars which we partner or out-license. We are focused on advancing and expanding our product portfolio to increase patient access to these much-needed therapies.

Contract development and manufacturing

We have fully integrated solutions to support academic, small biotech and large pharma's biologic development projects from early stage discovery through to commercial supply.

Find out more

Who we work with

Whether you are at an academic institution looking to get your idea off the ground or part of one of the worlds largest biotechnology companies, we have solutions to fit your needs, from pre-clinical to commercial.

Learn more

Our sites

With state-of-the-art facilities across Europe, Polpharma Biologics is at the forefront of the next wave in biotechnology, leveraging our knowledge, capabilities and footprint to develop innovative solutions for the industry.

Gdańsk

Our Gdansk site includes mammalian and microbial R&D and manufacturing facilities for mid-scale production including drug product and fill finish.

Warsaw

Our Warsaw site is one of the largest biologics manufacturing sites in Europe, with capabilities for preclinical, clinical and commercial supply to EU and US standards.

Utrecht

Our Utrecht site is one of innovation and leads the discovery, optimization and development of novel biologics and biosimilars as well as being home to our industry leading cell line development platform.

Our sites

Learn more

Gdańsk

Our Gdansk site includes mammalian and microbial R&D and manufacturing facilities for mid-scale production including drug product and fill finish.
Warsaw

Our Warsaw site is one of the largest biologics manufacturing sites in Europe, with capabilities for preclinical, clinical and commercial supply to EU and US standards.
Utrecht

Our Utrecht site is one of innovation and leads the discovery, optimization and development of novel biologics and biosimilars as well as being home to our industry leading cell line development platform.

Learn more

Innovation in Poland

Over the last decade Polpharma Biologics has created a biotechnology sector almost from scratch in Poland. We consistently invest, not only laboratories and production lines, but also in know-how, driving growth of highly-qualified jobs, as well as developing cooperation between science and business.

Learn more